                         SEQUENCE LISTING

<110>  Dana-Farber Cancer Institute, Inc.
 
<120>  HIGH THROUGHPUT BH3 PROFILING: A RAPID AND SCALABLE 
       TECHNOLOGY TO BH3 PROFILE ON LOW NUMBERS OF CELLS

<130>  D0504.70085WO00

<140>  Not Yet Assigned
<141>  Concurrently Herewith

<150>  US 62/153,475
<151>  2015-04-27

<160>  17    

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Modified by Ac

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  AMIDATION

<400>  1

Met Arg Pro Glu Ile Trp Ile Ala Gln Glu Leu Arg Arg Ile Gly Asp 
1               5                   10                  15      


Glu Phe Asn Ala 
            20  


<210>  2
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Modified by AC

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  AMIDATION

<400>  2

Met Arg Pro Glu Ile Trp Ile Ala Gln Glu Leu Arg Arg Ile Gly Asp 
1               5                   10                  15      


Glu Phe Asn Val 
            20  


<210>  3
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  3

Glu Asp Ile Ile Arg Asn Ile Ala Arg His Leu Ala Gln Val Gly Asp 
1               5                   10                  15      


Ser Met Asp Arg 
            20  


<210>  4
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  4

Met Arg Pro Glu Ile Trp Ile Ala Gln Glu Leu Arg Arg Ile Gly Asp 
1               5                   10                  15      


Glu Phe Asn Ala 
            20  


<210>  5
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  5

Glu Asp Ile Ile Arg Asn Ile Ala Arg His Ala Ala Gln Val Gly Ala 
1               5                   10                  15      


Ser Met Asp Arg 
            20  


<210>  6
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  6

Leu Trp Ala Ala Gln Arg Tyr Gly Arg Glu Leu Arg Arg Met Ser Asp 
1               5                   10                  15      


Glu Phe Glu Gly Ser Phe Lys Gly Leu 
            20                  25  


<210>  7
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  7

Met Glu Gly Ser Asp Ala Leu Ala Leu Arg Leu Ala Cys Ile Gly Asp 
1               5                   10                  15      


Glu Met Asp Val 
            20  


<210>  8
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  8

Ala Glu Leu Pro Pro Glu Phe Ala Ala Gln Leu Arg Lys Ile Gly Asp 
1               5                   10                  15      


Lys Val Tyr Cys 
            20  


<210>  9
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  9

Pro Ala Asp Leu Lys Asp Glu Cys Ala Gln Leu Arg Arg Ile Gly Asp 
1               5                   10                  15      


Lys Val Asn Leu 
            20  


<210>  10
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  10

Ala Ala Gln Leu Thr Ala Ala Arg Leu Lys Ala Leu Gly Asp Glu Leu 
1               5                   10                  15      


His Gln 
        


<210>  11
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  11

Glu Gln Trp Ala Arg Glu Ile Gly Ala Gln Leu Arg Arg Met Ala Asp 
1               5                   10                  15      


Asp Leu Asn Ala 
            20  


<210>  12
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  12

His Gln Ala Glu Val Gln Ile Ala Arg Lys Leu Gln Leu Ile Ala Asp 
1               5                   10                  15      


Gln Phe His Arg 
            20  


<210>  13
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  13

Asn Leu Trp Ala Ala Gln Arg Tyr Gly Arg Glu Leu Arg Arg Met Ser 
1               5                   10                  15      


Asp Glu Phe Val Asp Ser Phe Lys Lys 
            20                  25  


<210>  14
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  14

Leu Trp Ala Ala Gln Arg Tyr Gly Arg Glu Ala Arg Arg Met Ser Asp 
1               5                   10                  15      


Glu Phe Glu Gly Ser Phe Lys Gly Leu 
            20                  25  


<210>  15
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  15

Arg Pro Glu Ile Trp Met Thr Gln Gly Leu Arg Arg Leu Gly Asp Glu 
1               5                   10                  15      


Ile Asn Ala Tyr Tyr Ala Arg 
            20              


<210>  16
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  16

Glu Gln Trp Ala Arg Glu Ile Gly Ala Gln Ala Arg Arg Met Ala Ala 
1               5                   10                  15      


Asp Leu Asn Ala 
            20  


<210>  17
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  misc_feature
<222>  (1)..(10)
<223>  Xaa can be any amino acid

<220>
<221>  misc_feature
<222>  (12)..(15)
<223>  Xaa can be any amino acid

<220>
<221>  misc_feature
<222>  (17)..(20)
<223>  Xaa can be any amino acid

<400>  17

Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Leu Xaa Xaa Xaa Xaa Asp 
1               5                   10                  15      


Xaa Xaa Xaa Xaa 
            20  


